Summary
Overview
Work History
Education
Languages
Timeline
Affiliations
Generic
Quentin Spilliaert, MD

Quentin Spilliaert, MD

Basel

Summary

Results-driven Medical Affairs leader with a proven ability to steer cross-functional efforts, navigate complex landscapes, and execute strategic initiatives internationally. Known for a structured and pragmatic approach, I bring a strong operational focus to complement strategic vision. Dedicated to positioning the pharmaceutical industry as a reliable contributor to the healthcare value chain, I focus on leveraging Medical Affairs to maximize the impact of innovative therapies in addressing unmet medical needs.

Overview

6
6
years of professional experience

Work History

Region Europe Medical Lead

Novartis Gene Therapies and Rare Diseases
Basel
09.2023 - Current
  • Managing the Europe Medical Affairs plan, overseeing the Regional medical budget also encompassing grants and Investigator-Initiated Trials (IITs), ensuring tactical harmonization across countries, and aligning with Global strategic priorities.
  • Serving as the leader of the European medical team, bridging the gap between the Global team and country teams to facilitate effective implementation of the product strategy.
  • Advocating for the priorities and requirements of the European region, a pivotal market, drawing upon extensive familiarity with the product and collaboration with world-renowned experts.
  • Established as a trusted scientific partner within the Spinal Muscular Atrophy (SMA) Medical Community.
  • Successfully executing business-critical projects at the Regional level, including advisory boards, congress symposia, and similar initiatives.
  • Adapting Global tactics and scientific communication materials to meet the specific needs of individual countries, contributing to effective regionalization.
  • Acting as the representative of Medical Affairs in Regional cross-functional meetings, review committees, and compliance processes.

Region Europe Medical Program Lead (assignment)

Novartis Gene Therapies and Rare Diseases
Basel
10.2021 - 09.2023
  • Contributed to the development of the Ocular Gene Therapy Regional medical strategy.
  • Made substantial contributions to both the Global Team and the Global Product Team.
  • Managed the consolidation of the Integrated Evidence Plan, overseeing the identification of data/knowledge gaps and monitoring all evidence-generating activities.
  • Provided support to European countries in the implementation of their genetic testing initiatives.
  • Held responsibility for the Treatment Center Onboarding Program and initiatives focused on Treatment Centers.
  • Led various key strategic projects with Regional/Global scope, guiding cross-functional project teams and collaborating with Global medical experts.
  • Maintained active and continuous engagement with country medical leads, offering support, soliciting input, and fostering team cohesion.
  • Monitored medical activities, metrics, and budget across Region Europe.
  • Established connections with other regions to exchange experiences, provide feedback, and identify synergies.

Cluster Medical Lead, Gene Therapy

Novartis
08.2019 - 09.2023
  • In a matrix organization collaborating with local Brand Teams and Region Europe management, formulated individual country medical strategies that resulted in successful reimbursement and launch in five countries.
  • Oversaw the onboarding and certification of up to seven treatment centers in accordance with the EMA-approved and audited Risk Management Plan (RMP) for Gene Therapy.
  • Provided supervision and coaching to country medical associates within the Western European Countries (WEC) Region.
  • Effectively executed five investigator-initiated trials and established research collaborations with prominent institutions, contributing to transformative studies with a global impact.

Medical Science Liaison

Novartis
Vilvoorde
08.2017 - 08.2019
  • Established scientific collaborations focused on migraine in Wallonia and Luxemburg, playing a pivotal role in elevating Belgium to the position of the number one country worldwide in Early Access Program participation.
  • Provided support in defining and implementing strategies, including the training of a new salesforce in the highly competitive landscape of Multiple Sclerosis.

Education

Executive Master - Management

Solvay Business School
Brussels, Belgium
06.2019

M.D. - Medicine

Catholic University of Louvain (UCL)
Brussels, Belgium
06.2016

Bachelor of Arts - Philosophy

Catholic University of Louvain (UCL)
SpilliaertLouvain-la-Neuve, Belgium
06.2013

Languages

French
First Language
English
Proficient
C2
Dutch
Upper Intermediate
B2

Timeline

Region Europe Medical Lead

Novartis Gene Therapies and Rare Diseases
09.2023 - Current

Region Europe Medical Program Lead (assignment)

Novartis Gene Therapies and Rare Diseases
10.2021 - 09.2023

Cluster Medical Lead, Gene Therapy

Novartis
08.2019 - 09.2023

Medical Science Liaison

Novartis
08.2017 - 08.2019

Executive Master - Management

Solvay Business School

M.D. - Medicine

Catholic University of Louvain (UCL)

Bachelor of Arts - Philosophy

Catholic University of Louvain (UCL)

Affiliations

Earned top honors in the International Grand Piano Competition in Paris, achieving the first position in my age category at the age of 10.

Currently immersed in the exploration of C.G. Jung's "Symbols of Transformation."

Dedicated practitioner of hot yoga and cross-fit training.

Similar Profiles

CREATE PROFILE
Quentin Spilliaert, MD